Reduced thrombus formation in native blood of homozygous factor VII- deficient patients at high arterial wall shear rate

Autor: RM Barstad, H Stormorken, L Orning, RW Stephens, LB Petersen, P Kierulf, KS Sakariassen

Publikováno v: Blood. 84:3371-3377

Inhibition of thrombin formation in flowing native blood reduces thrombus formation on subendothelium, dacron, or collagen fibrils at arterial wall shear rates of 450 to 650 s-1. In the present study, we have investigated the role of low levels of fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::877fbdcea58886ba555245702ade621c
https://doi.org/10.1182/blood.v84.10.3371.bloodjournal84103371

Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer

Autor: Kos J, Hans Jørgen Nielsen, Krasovec M, Ij, Christensen, Cimerman N, Rw, Stephens, Brünner N

Publikováno v: Publons
Europe PubMed Central

The level of cathepsin B (Cat B) was determined in sera obtained preoperatively from 325 patients with colorectal cancer using an ELISA. Control sera from 90 healthy blood donors were analyzed. The levels of Cat B detected included all forms that wer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::36be9ca688067a0d6027e3cdf12f6226
https://pubmed.ncbi.nlm.nih.gov/9626470

Neutralizing the pathological effects of extracellular histones with small polyanions.

Autor: Meara CHO; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Coupland LA; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Kordbacheh F; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Quah BJC; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Chang CW; Institute for Glycomics, Griffith University, Gold Coast, QLD, 4222, Australia., Simon Davis DA; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Bezos A; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Browne AM; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Freeman C; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Hammill DJ; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia., Chopra P; Institute for Glycomics, Griffith University, Gold Coast, QLD, 4222, Australia., Pipa G; Institute for Glycomics, Griffith University, Gold Coast, QLD, 4222, Australia., Madge PD; Institute for Glycomics, Griffith University, Gold Coast, QLD, 4222, Australia., Gallant E; Eccles Institute of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, 2601, Australia., Segovis C; Eccles Institute of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, 2601, Australia., Dulhunty AF; Eccles Institute of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, ACT, 2601, Australia., Arnolda LF; Illawarra Health and Medical Research Institute, Wollongong, NSW, 2500, Australia., Mitchell I; Intensive Care Unit, The Canberra Hospital, Garran, Canberra, ACT, 2605, Australia., Khachigian LM; Vascular Biology and Translational Research, School of Medical Sciences, University of New South Wales, Sydney, NSW, 2052, Australia., Stephens RW; Department of Applied Mathematics, Research School of Physics and Engineering, The Australian National University, Canberra, ACT, 2601, Australia., von Itzstein M; Institute for Glycomics, Griffith University, Gold Coast, QLD, 4222, Australia., Parish CR; ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia. christopher.parish@anu.edu.au.

Publikováno v: Nature communications [Nat Commun] 2020 Dec 16; Vol. 11 (1), pp. 6408. Date of Electronic Publication: 2020 Dec 16.

^99m Tc-radiolabeled composites enabling in vivo imaging of arterial dispersal and retention of microspheres in the vascular network of rabbit lungs, liver, and liver tumors.

Autor: Stephens RW; The Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Canberra, ACT, Australia, greg.tredwell@anu.edu.au., Tredwell GD; The Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Canberra, ACT, Australia, greg.tredwell@anu.edu.au., Knox KJ; The Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Canberra, ACT, Australia, greg.tredwell@anu.edu.au., Philip LA; The Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Canberra, ACT, Australia, greg.tredwell@anu.edu.au., King DW; The Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Canberra, ACT, Australia, greg.tredwell@anu.edu.au., Debono KM; Animal Services Division, Research School of Biology, Australian National University, Canberra, ACT, Australia., Bell JL; The Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Canberra, ACT, Australia, greg.tredwell@anu.edu.au., Senden TJ; The Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Canberra, ACT, Australia, greg.tredwell@anu.edu.au., Tanudji MR; Research and Development, Sirtex Medical Limited, Sydney, NSW, Australia., Winter JG; Research and Development, Sirtex Medical Limited, Sydney, NSW, Australia., Bickley SA; Research and Development, Sirtex Medical Limited, Sydney, NSW, Australia., Tapner MJ; Research and Development, Sirtex Medical Limited, Sydney, NSW, Australia., Jones SK; Research and Development, Sirtex Medical Limited, Sydney, NSW, Australia.

Publikováno v: International journal of nanomedicine [Int J Nanomedicine] 2019 Jan 31; Vol. 14, pp. 889-900. Date of Electronic Publication: 2019 Jan 31 (Print Publication: 2019).

The uptake of soluble and nanoparticulate imaging isotope in model liver tumours after intra-venous and intra-arterial administration.

Autor: Stephens RW; Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Australia. Electronic address: ross.stephens@anu.edu.au., Knox KJ; Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Australia., Philip LA; Animal Services Division, Research School of Biology, Australian National University, Australia., Debono KM; Animal Services Division, Research School of Biology, Australian National University, Australia., Bell JL; Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Australia., King DW; Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Australia., Parish CR; Vascular Biology Laboratory, John Curtin School of Medical Research, Australian National University, Australia., Senden TJ; Biomedical Radiochemistry Laboratory, Department of Applied Mathematics, Research School of Physics and Engineering, Australian National University, Australia., Tanudji MR; Sirtex Medical Ltd, Sydney, Australia., Winter JG; Sirtex Medical Ltd, Sydney, Australia., Bickley SA; Sirtex Medical Ltd, Sydney, Australia., Tapner MJ; Sirtex Medical Ltd, Sydney, Australia., Pang JH; Sirtex Medical Ltd, Sydney, Australia., Jones SK; Sirtex Medical Ltd, Sydney, Australia.

Publikováno v: Biomaterials [Biomaterials] 2015 Jan; Vol. 39, pp. 218-24. Date of Electronic Publication: 2014 Nov 20.